LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹581 Cr | ₹510 Cr | ₹472 Cr | ₹424 Cr | ₹386 Cr |
What is the latest Revenue of LINCOLN PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹581 Cr |
Mar2023 | ₹510 Cr |
Mar2022 | ₹472 Cr |
Mar2021 | ₹424 Cr |
Mar2020 | ₹386 Cr |
How is Revenue of LINCOLN PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹581 Cr | 13.76 | |
Mar2023 | ₹510 Cr | 8.09 | |
Mar2022 | ₹472 Cr | 11.30 | |
Mar2021 | ₹424 Cr | 9.75 | |
Mar2020 | ₹386 Cr | - |
Compare Revenue of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,569.8 Cr | -3.8% | 24.7% | 31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.8% |
24.7% |
31.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses